hellocare.ai Raises $47M to Accelerate AI-Assisted Virtual Care and Transform Hospital Rooms into Smart, Connected Care Environments
Delivering Proven ROI in Smart Hospital Room Technology Across 70+ Health Systems
CLEARWATER, Fla., April 15, 2025 /PRNewswire/ -- hellocare.ai, the leading AI-assisted virtual care delivery platform transforming hospital care models and operations, today announced it has raised $47 million in an oversubscribed funding growth round. The round was led by HealthQuest Capital, with participation from a strategic coalition of forward-thinking health systems and digital health investors, including Bon Secours Mercy Health, UCHealth, OSF Ventures, and LRVHealth.
Already deployed across 70+ health systems, the investment fuels a period of hyper-growth for hellocare.ai, as demand accelerates for its unified virtual care platform. The platform that enables hospitals to deliver AI-assisted Virtual Nursing, Virtual Sitting, Virtual Consultation, Ambient Documentation, Digital Whiteboards, Patient Engagement, and Hospital-at-Home—all through one deeply integrated, enterprise-ready solution. The advancement and convergence of artificial intelligence and immersive virtual to physical care technologies have fueled the demand for smart hospital rooms, representing an opportunity to support healthcare delivery across the continuum of care.
'This raise represents a powerful vote of confidence in our mission and model,' said Labinot Bytyqi, Founder and CEO of hellocare.ai. 'Health systems are asking for a proven, unified virtual care platform to simplify care delivery, drive clinical efficiency, reduce burnout, and increase patient engagement—and that's exactly what we've built. With this funding, we're partnering with some of the leading health systems to scale fast and go deeper into AI to solve healthcare's toughest care delivery and operational challenges.'
'hellocare.ai's technology and vision are very closely aligned with the evolving needs of health systems,' said Randy Scott, Partner at HealthQuest Capital. 'They are solving real problems at scale, with a practical and powerful platform that delivers measurable impact.'
A New Standard for Virtual Care and Patient Engagement
hellocare.ai is the only purpose-built platform on the healthcare market with a fully in-house technology stack—encompassing hardware, software, AI, and a seamless EHR integration engine. This end-to-end approach delivers unmatched speed, customization, and continuous innovation. Paired with AI and flexible hybrid clinical care team models, hellocare.ai empowers health systems to rapidly scale hybrid care, deliver high-quality care from anywhere, and create a truly patient-centric experience—all through a single, unified platform.
Trusted by Leading Health Systems
Already deployed across 70+ health systems, hellocare.ai is replacing fragmented point solutions and delivering meaningful ROI—transforming any hospital room into a smart, connected care environment. In a major milestone, AdventHealth is rolling out hellocare.ai across more than 50 hospitals and over 13,000 patient rooms as part of an enterprise-wide implementation to enhance patient experience, streamline clinical workflows, and drive operational efficiency.
Both Bon Secours Mercy Health and UCHealth are not only investors in this round but also customers of hellocare.ai—actively deploying the platform to reimagine virtual care delivery and elevate patient engagement across their systems. Their dual role highlights the deep alignment between hellocare.ai's innovation roadmap and the real-world needs of modern health systems.
'Our partnership with hellocare.ai will allow us to improve safety, reduce readmissions, optimize staff workflows and improve patient experience in our hospitals,' said Mark Townsend, MD, MHCM, chief clinical digital ventures officer, Bon Secours Mercy Health and Accrete Health Partners. 'Investing in novel digital health technologies enables our health system to be at the forefront of digital transformation, with the intent of making health care as easy as possible for patients and providers.'
About hellocare.ai
hellocare.ai is a leading provider of AI-assisted virtual care solutions. Headquartered in Clearwater, FL, the company supports more than 70 health systems across the U.S. and is rapidly expanding globally. hellocare.ai helps health systems deliver high-quality, patient-centered care while improving clinical efficiency and staff wellbeing. Its fully integrated platform includes AI-Assisted Virtual Nursing, Virtual Sitting, Patient Engagement, Digital Whiteboard, Digital Room Signage, Ambient Documentation, Hospital-at-Home, Remote Patient Monitoring (RPM), and Digital Clinic—seamlessly embedding into existing healthcare EHRs, infrastructure, and care delivery models to power the next generation of healthcare. For more information, visit https://hellocare.ai
About HealthQuest Capital
HealthQuest Capital is a private asset firm that provides capital to transformative healthcare companies. HealthQuest Capital focuses on commercial prospects that drive enhanced patient outcomes and elevate the efficiency of healthcare delivery. With approximately $2 billion in capital under management, the firm focuses on fostering innovation across the healthcare spectrum, including medical technologies, diagnostics, digital health, and innovative services. The HealthQuest Capital team combines decades of investing experience with domain expertise in the various aspects of the healthcare industry. For more information, visit www.healthquestcapital.com
For inquiries, contact:
Mimoza Buonsanti
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/hellocareai-raises-47m-to-accelerate-ai-assisted-virtual-care-and-transform-hospital-rooms-into-smart-connected-care-environments-302427478.html
SOURCE hellocare
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Latest Economy Observer report from Dun & Bradstreet reveals India's steady rise as inflation eases and financial markets strengthen
MUMBAI, India, June 9, 2025 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, has released its Economy Observer report for June 2025. Economy Observer is a monthly report sharing in-depth analysis of key macroeconomic developments in India and provides forecasts for key economic indicators, and insight into the expected direction of the Indian economy. Key economic forecast: Real Economy: India's GDP in the final quarter of FY25 expanded by an impressive 7.4% from the provisional estimate of 6.5%. Looking ahead, D&B forecasts a moderation in India's Industrial Production Index (IIP) to 1.8% in May from 2.7% in April— reflecting a combination of cyclical and sector-specific weaknesses. Domestic demand is robust, and international ties are improving. Industrial growth faces short-term headwinds. These include base effects, inventory corrections (destocking), and supply disruptions caused by the early monsoon season. Urban demand is expected to pick up due to tax exemptions taking effect from April, while an early monsoon should boost the kharif season, supporting rural consumption—especially durables and e-commerce. Price Scenario: India's inflation trajectory continues to improve, reinforcing price stability. Dun & Bradstreet forecasts CPI inflation to follow its current downward trajectory to 3.0% in May from 3.2% in April, driven primarily by sustained disinflation in food prices. Food and beverages inflation has cooled down to its lowest in over a year, led by sharp corrections in vegetables and pulses. While unseasonal weather caused intermittent volatility, proactive release of buffer stocks by the Food Corporation of India helped contain cereal inflation and dampen broader food price pressures. Dun & Bradstreet forecasts WPI inflation to fall to 0.7% in May, from 0.9% in April, reflecting weak input cost pressures, subdued global commodity prices, and a supportive base effect. Notably, the recent surge in global copper prices has yet to significantly impact wholesale price indices but may influence industrial cost structures in the coming months. Money & Finance: India's financial markets in May 2025 exhibit growing stability, supported by easing inflation, improved liquidity, and a stronger fiscal position. Dun & Bradstreet projects the 10-year G-Sec yield to ease to 6.4% and the 91-day T-Bill to 5.9%, reflecting better borrowing conditions. The RBI's ₹40,000 crore OMO purchase and a record ₹2.7 lakh crore dividend transfer to the government have bolstered liquidity and reduced bond supply pressures. Bank credit growth has moderated to 10.0%, indicating recalibrated demand and cautious lending amid tighter digital lending oversight. The RBI's decision to raise the Contingent Risk Buffer to 7.5% signals growing confidence in financial system resilience. Structural reforms, including the launch of '. and ' domains, enhance cybersecurity in digital finance, while formalization trends are curbing currency circulation. External Sector: In May 2025, the Indian rupee appreciated to ₹85.3/USD, Dun & Bradstreet forecasts Rupee to stabilize around ₹85.4 in June. The currency's strength was supported by reduced capital outflows, RBI's calibrated liquidity support and rate adjustments, which reinforced monetary stability, as well as a weakening of the dollar. A narrower trade deficit due to lower non-essential imports and sustained FII inflows improved the balance of payments. A steepening yield curve and notable declines in 5- and 10-year yields underscored strong demand for Indian debt. Going forward, the rupee is well positioned to defend its gains, backed by robust fundamentals and investor confidence. Arun Singh, Global Chief Economist, Dun & Bradstreet, said, "India's short-term economic outlook remains strong as GDP in the final quarter of FY25 expanded by an impressive 7.4% —a symbolic milestone that reinforces investor confidence. A pick-up in urban consumption—spurred by pre-festive spending, tax reliefs, and a favorable base—is cushioning overall growth. Meanwhile, an early and widespread monsoon is expected to lift rural demand, particularly in agri-linked sectors. Headline inflation remains manageable, aided by easing food prices and supply-side interventions. Financial markets continue to show momentum, with strong equity performance, stable bond yields, and robust foreign portfolio inflows. The rupee has appreciated mildly, reflecting improved current account dynamics and positive sentiment. In the short run, policy support and macro stability are expected to anchor growth amid global volatility." D&B's Economy Observer Forecast Variables Forecast** Latest Period Previous period IIP Growth 1.8% May-25 2.7%April-25 3.0%Mar-25 Inflation WPI 0.7% May-25 0.9% April 25 2.0% Mar-25 CPI (Combined) 3.0% May-25 3.2% April-25 3.3% Mar-25 Exchange Rate (INR/USD) * 85.4 June-25 85.3 May-25 85.7 Apr 25 91-day T-Bills* 5.9% May-25 6.0% April-25 6.5% Mar-25 10-year G-Sec Yield* 6.4% May-25 6.5% April-25 6.7% Mar-25 Bank Credit 10.0% May-25 10.9%April-25 11% Mar-25 *Weekly Average ** Dun and Bradstreet Forecasts About Dun & Bradstreet: Dun & Bradstreet, a leading global provider of business decisioning data and analytics, enables companies around the world to improve their business performance. Dun & Bradstreet's Data Cloud fuels solutions and delivers insights that empower customers to accelerate revenue, lower cost, mitigate risk and transform their businesses. Since 1841, companies of every size have relied on Dun & Bradstreet to help them manage risk and reveal opportunity. For more information on Dun & Bradstreet, please visit Dun & Bradstreet Information Services India Private Limited is headquartered in Mumbai and provides clients with data-driven products and technology-driven platforms to help them take faster and more accurate decisions across finance, risk, compliance, information technology and marketing. Working towards Government of India's vision of creating an Atmanirbhar Bharat (Self-Reliant India) by supporting the Make in India initiative, Dun & Bradstreet India has a special focus on helping entrepreneurs enhance their visibility, increase their credibility, expand access to global markets, and identify potential customers & suppliers, while managing risk and opportunity. India is also the home to Dun & Bradstreet Technology & Corporate Services LLP, which is the Global Capabilities Center (GCC) of Dun & Bradstreet supporting global technology delivery using cutting-edge technology. Located at Hyderabad, the GCC has a highly skilled workforce of over 500 employees, and focuses on enhanced productivity, economies of scale, consistent delivery processes and lower operating expenses. Visit for more information. Click here for all Dun & Bradstreet India press releases. Logo: View original content:
Yahoo
an hour ago
- Yahoo
BEAUTYEXPO & COSMOBEAUTÉ MALAYSIA 2025 RETURNS TO DAZZLE THE BEAUTY INDUSTRY WITH INFINITE POSSIBILITIES
Visitor Registration is Now Open KUALA LUMPUR, Malaysia, June 9, 2025 /PRNewswire/ -- Southeast Asia's beauty industry is set for a transformative experience as the 23rd edition of beautyexpo and 20th edition of Cosmobeauté Malaysia prepare to dazzle at the Kuala Lumpur Convention Centre (KLCC) from 30 September – 3 October 2025. Visitor registration for this can't-miss trade show is now open! As Malaysia's largest and longest-running beauty trade shows, BECBM offers an extraordinary showcase of innovation and excellence. Over 400 visionary exhibitors from across 9 countries and regions including Malaysia, Mainland China, Indonesia, Japan, Korea, Pakistan, Taiwan, Thailand and United Arab Emirates will unveil groundbreaking products, services, and technologies across eight specialised sectors: Professional Beauty, Hair & Barber, Makeup & Cosmetics, Nail, Embroidery & Lashes, OEM/ODM, Halal Beauty, Training & Certification, and Spa & Wellness. With more than 15,000 beauty professionals and buyers expected from over 60 countries and regions, this event solidifies Malaysia's position as the epicentre for Southeast Asia's beauty industry. "For over two decades, beautyexpo & Cosmobeauté Malaysia have consistently driven innovation, business, and cross-border collaboration within the beauty sector. The 2025 edition will elevate this legacy – fostering strong synergies between established industry leaders and emerging innovators while unlocking new opportunities across the Asia-Pacific region," said Tan Sri Abdul Rahman Mamat, Organising Chairman of beautyexpo & Cosmobeauté Malaysia. This year's edition will spotlight immersive experiences, live competitions, and insightful knowledge sharing. Key highlights include: Industry Seminars: Deep-dive sessions led by global beauty experts unveiling next-generation trends and techniques. Bloom & Groom: Skin Management Competition 2025: The highly anticipated second edition of the Skin Care Mastery Challenge, spotlighting exceptional professional skincare expertise. The 5th Malaysia Glory Cup International Beauty Competition: Celebrating elite artistry in embroidery, eyelashes, and nails with top-tier international talent. VIP Buyer Programme with Exclusive Perks and Trade Opportunities Spend & Win Campaign to Reward Visitors "We've reimagined the 2025 editions with both business and creativity in mind. From competitive showcases to business matchmaking, the entire experience is designed to help the industry connect, learn, and grow together, while also elevating Malaysia's leadership in specialised beauty segments like halal-certified products," added Tan Sri Abdul Rahman Mamat. A centrepiece of the exhibition is the expanded Halal Beauty pavilion, representing one of the industry's fastest-growing segments driven by ethical manufacturing, ingredient transparency, and surging consumer demand for clean, certified products. As a global authority in halal certification and industry development, Malaysia is uniquely positioned to lead this movement, and beautyexpo & Cosmobeauté Malaysia 2025 will amplify that role. From halal-certified cosmetics to innovative skincare and wellness offerings, visitors will discover a comprehensive showcase responding to evolving global preferences for safer, more inclusive, and ethically produced beauty solutions. This segment also opens doors for cross-border collaborations, especially among emerging brands looking to access Muslim-majority markets in Southeast Asia, the Middle East, and beyond. The event unites leading industry associations including the Kuching Association of Beauty Therapy & Cosmetology (KABTAC), Malaysian Hairdressing Association (MHA), Malaysia Cosmetology Chamber of Commerce (PAMM), and United Asian Hairdressers Association (UAHA), ensuring comprehensive industry representation and engagement. Visitor registration for BECBM 2025 is now open! Don't miss this chance to build valuable connections, gain in-depth insights, and stay at the forefront of the dynamic beauty industry. Register your visit at by 29 September to enjoy free admission! After this date, a fee of RM 20 will apply. To exhibit at beautyexpo & Cosmobeauté Malaysia, please email For more information about beautyexpo & Cosmobeauté Malaysia 2025, visit the official websites: and NOTES TO EDITORS:ABOUT INFORMA MARKETS ( Informa Markets on Beauty segment has an extensive network powered by B2B events across 11 cities in Asia (Bangkok, Chengdu, Ho Chi Minh City, Hong Kong, Jakarta, Kuala Lumpur, Manila, Mumbai, Shanghai, Shenzhen, Tokyo), the world's fastest growing markets. By further expanding its strength, the Beauty Portfolio now includes a new B2B event in Miami serving the East coast and USA, South America and Caribbean Islands regions. beautyexpo & Cosmobeauté Malaysia is organised by Informa Markets, a division of Informa plc. Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world's leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit View original content to download multimedia: SOURCE beautyexpo & Cosmobeauté Malaysia
Yahoo
3 hours ago
- Yahoo
28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains
Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLEANS, June 9, 2025 /PRNewswire/ -- 28bio today announced the Nexon™ neurotechnology platform—a major advancement in understanding human brain function. The platform integrates tissue engineering, neural interfacing and AI to engineer human brains at-scale and replicate complex neurological processes. The Nexon™ platform is now being used to improve the prediction of therapeutic efficacy and toxicity in humans, with several of the world's largest pharma companies already integrating Nexon™ into their drug development workflows. The Nexon™ platform also incorporates Organoid Intelligence (OI). The growing field of OI combines human brain organoids with brain-machine interfaces to model memory, learning, and cognition in vitro, offering novel functional cognitive biomarkers with the potential to reshape drug development in neurodegenerative disorders including Alzheimer's disease. Neurological drug development faces some of the highest failure rates in the pharmaceutical industry, due to poor translatability of animal models. Despite promising preclinical study results, many therapies ultimately fail in humans—contributing to a growing neurological health crisis and need for more predictive, human-relevant models. "We engineer human brains capable of elucidating the complexity of neurological processes and produce predictive data needed to change the trajectory of neurological drug development," said Alif Saleh, CEO of 28bio. "Industry and regulators are urgently asking for solutions to develop better neurological drugs faster and cheaper." About 28bio28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today's neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition. For more information, visit View original content to download multimedia: SOURCE 28bio Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
